Antiaging Quantum Living Inc. Files 10-K/A Amendment

TL;DR

<b>Antiaging Quantum Living Inc. has filed an amended 10-K report for the fiscal year ending March 31, 2024.</b>

AI Summary

Antiaging Quantum Living Inc. (AAQL) filed a Amended Annual Report (10-K/A) with the SEC on May 16, 2024. Antiaging Quantum Living Inc. filed an amended 10-K on May 16, 2024. The company's fiscal year ends on March 31. The filing covers the period ending March 31, 2024. The company was formerly known as Achison Inc. and changed its name on April 19, 2016. The business and mailing address is located at 135-22 Northern Blvd, 2nd Fl, Flushing, NY 11354.

Why It Matters

For investors and stakeholders tracking Antiaging Quantum Living Inc., this filing contains several important signals. This amended filing provides updated financial and operational information for the fiscal year. The name change from Achison Inc. indicates a potential shift in business focus or strategy.

Risk Assessment

Risk Level: — Antiaging Quantum Living Inc. shows moderate risk based on this filing. The filing is an amendment to a 10-K, suggesting it's a routine update or correction rather than a new material event.

Analyst Insight

Review the amended 10-K for any significant changes in financial performance, business operations, or risk factors compared to the original filing.

Key Numbers

• 2024-03-31 — Fiscal Year End (Period of report)
• 2024-05-16 — Filing Date (Date the 10-K/A was filed)
• 2016-04-19 — Name Change Date (Date Antiaging Quantum Living Inc. changed from Achison Inc.)

Key Players & Entities

• Antiaging Quantum Living Inc. (company) — Filer name
• Achison Inc. (company) — Former company name
• 2024-05-16 (date) — Filing date
• 2024-03-31 (date) — Period of report
• 135-22 Northern Blvd, 2nd Fl, Flushing, NY 11354 (address) — Business and mailing address

FAQ

Industry Context

The company operates in the direct mail advertising services sector.

Regulatory Implications

The filing is a 10-K/A, an amendment to the annual report, filed under the Securities Exchange Act of 1934.

What Investors Should Do

1. Examine the specific changes and additions made in the 10-K/A filing.
2. Verify if the amendment clarifies any previously ambiguous information.
3. Assess the impact of any disclosed changes on the company's financial health and future prospects.

Year-Over-Year Comparison

This is an amended filing (10-K/A), indicating updates or corrections to a previously submitted annual report.

Key Financial Figures

• $5.00 — ty that has a market price of less than $5.00 per share or with an exercise price of
• $0.88 — n stock reported on the OTC Markets was $0.88 per share. The following table sets for

Filing Documents

• form10-ka.htm (10-K/A) — 647KB
• ex31-1.htm (EX-31.1) — 18KB
• ex31-2.htm (EX-31.2) — 18KB
• ex32-1.htm (EX-32.1) — 9KB
• form10-ka_001.jpg (GRAPHIC) — 36KB
• 0001493152-24-020108.txt (&nbsp;) — 3312KB
• achn-20240331.xsd (EX-101.SCH) — 25KB
• achn-20240331_cal.xml (EX-101.CAL) — 47KB
• achn-20240331_def.xml (EX-101.DEF) — 78KB
• achn-20240331_lab.xml (EX-101.LAB) — 212KB
• achn-20240331_pre.xml (EX-101.PRE) — 164KB
• form10-ka_htm.xml (XML) — 356KB

Business

Business 3 Item 1A.

Risk Factors

Risk Factors 5 Item 1B. Unresolved Staff Comments 5 Item 2.

Properties

Properties 5 Item 3.

Legal Proceedings

Legal Proceedings 5 Item 4. Mine Safety Disclosures 5 PART II Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 6 Item 6.

Selected Financial Data

Selected Financial Data 7 Item 7.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 7 Item 7A.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 9 Item 8.

Financial Statements and Supplementary Data

Financial Statements and Supplementary Data 9 Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 10 Item 9A.

Controls and Procedures

Controls and Procedures 10 Item 9B. Other Information 11 PART III Item 10. Directors, Executive Officers and Corporate Governance 11 Item 11.

Executive Compensation

Executive Compensation 13 Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 14 Item 13. Certain Relationships and Related Transactions, and Director Independence 15 Item 14. Principal Accounting Fees and Services 15 PART IV Item 15. Exhibits, Financial Statement Schedules 16

Signatures

Signatures 17 2 NOTE ABOUT FORWARD-LOOKING STATEMENTS The information contained in this Report includes some statements that are not purely historical and that are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and as such, may involve risks and uncertainties. These forward-looking statements relate to, among other things, expectations of the business environment in which we operate, perceived opportunities in the market and statements regarding our mission and vision. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. You can generally identify forward-looking statements as statements containing the words "anticipates," "believes," "continue," "could," "estimates," "expects," "intends," "may," "might," "plans," "possible," "potential," "predicts," "projects," "seeks," "should," "will," "would" and similar expressions, or the negatives of such terms, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking forward-looking statements. The forward-looking statements contained herein are based on various assumptions, many of which are based, in turn, upon further assumptions. Our expectations, beliefs and forward-looking statements are expressed in good faith on the basis of management's views and assumptions as of the time the statements are made, but there can be no assurance that management's expectations, beliefs or projections will result or be achieved or accomplished. In addition to other factors and matters discussed elsewhere herein, the following are importan

View Full Filing

View this 10-K/A filing on SEC EDGAR